Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
2(50.0%)
4Total
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07457918Phase 3Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Role: collaborator

NCT06564974Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

Role: collaborator

NCT07246590Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Role: collaborator

NCT05516940Completed

A Study of the Impact of Different Delivery Modes on Specific Macronutrient Components in Human Milk

Role: collaborator

NCT05160675Completed

Nutrition, Microbiome and Bone Health During Early Life Related to Health

Role: collaborator

NCT04880083Not ApplicableCompleted

Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein

Role: collaborator

NCT04763512Not ApplicableCompleted

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Role: collaborator

NCT04787926Terminated

DuraLock-C Catheter Lock Solution

Role: collaborator

NCT04782297Withdrawn

Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)

Role: collaborator

All 9 trials loaded